ADMA Biologics, Inc. (ADMA) vs Nurix Therapeutics, Inc. (NRIX)
A side-by-side comparison of ADMA Biologics, Inc. and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADMA
ADMA Biologics, Inc.
$10.17HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
NRIX
Nurix Therapeutics, Inc.
$22.63HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — ADMA vs NRIX
growth of $100 · dividends reinvested · last 6yADMA +216.9% (+21.2%/yr)NRIX +20.4% (+3.1%/yr)ADMA compounded faster over this window
ADMA NRIX
ADMA vs NRIX: by the numbers
- •ADMA is the larger company ($2.36B vs $2.35B market cap).
- •ADMA is profitable (32.98% net margin) while NRIX runs a net loss (-928.44%).
- •ADMA grew revenue faster over the past five years (54.55% vs 9.96% CAGR).
Metrics side by side
Valuation
| Metric | ADMA | NRIX |
|---|---|---|
| P/E ratio | 14.53 | N/A |
| Forward P/E | 12.77 | N/A |
| P/S ratio | 4.60 | 63.87 |
| P/B ratio | 5.77 | 5.83 |
| EV / EBITDA | 10.73 | N/A |
| FCF yield | 4.94% | N/A |
Profitability
| Metric | ADMA | NRIX |
|---|---|---|
| Gross margin | 64.71% | 77.55% |
| Operating margin | 42.26% | -340.16% |
| Net margin | 32.98% | -928.44% |
| ROE | 41.39% | -84.78% |
| ROIC | 27.60% | -77.92% |
Growth (annualized)
| Metric | ADMA | NRIX |
|---|---|---|
| Revenue CAGR (5Y) | 54.55% | 9.96% |
| Total return CAGR (5Y) | 54.74% | -5.51% |
Frequently asked
- Which has grown faster, ADMA or NRIX?
- Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus NRIX at 9.96%.
- Is ADMA or NRIX more profitable?
- ADMA runs the higher net margin — ADMA at 32.98% versus NRIX at -928.44%.
- How have ADMA and NRIX total returns compared?
- Over the past 5 years, ADMA delivered 54.74% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ADMA Biologics P/E ratioADMA Biologics ROENurix Therapeutics ROEADMA Biologics operating marginNurix Therapeutics operating marginADMA Biologics revenue growthNurix Therapeutics revenue growthADMA Biologics free cash flowNurix Therapeutics free cash flow
ADMA Biologics & Nurix Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.